Contact Supplier

Contact Supplier

To get in touch with MEGGLE Excipients, simply fill out the form below.

    Subscribe to Supplier

    Subscribe to Supplier


    MEGGLE showcasing latest DPI-focused InhaLac® 300 at PBP 2021

    news-releasesMEGGLE Excipients
    May 7th 2021

    Wasserburg, Germany: Pharmaceutical lactose specialist MEGGLE Wasserburg GmbH (MEGGLE) will present InhaLac® 300 as the latest addition to its advanced range of pharmaceutical lactose excipients at the upcoming online 12th Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology conference, PBP World Meeting 2021.

    MEGGLE has a long-standing relationship with the PBP series of biennial conferences, having regularly exhibited and posted at previous events held around Europe, most recently in Granada, Spain, in 2018.

    Virtual MEGGLE booth

    With its own virtual booth, MEGGLE will be a prominent presence at the redesigned online event, that will go live over four days from May 11, replacing the Vienna meeting originally scheduled for 2020 and cancelled due to the COVID-19 emergency.

    Members of MEGGLE’s R&D team will be available for online chats about the company’s excipients, with particular focus on InhaLac® 300, which has been developed as a fine-milled lactose excipient to support dry powder inhalation (DPI) formulations.

    MEGGLE will contribute a specific online poster presenting features and potential applications for the new excipient InhaLac® 300 on the final day of the conference, Friday, May 14.

    Bridging the DPI gap

    The new excipient’s specific particle size distribution with 90% of particles between 40 and 56 µm (Malvern) and characterized by the typical flow- and surface-characteristic of milled lactose grades allows it to bridge the gap between medium sized carrier lactoses and fine milled grades for dry powder inhalation (DPI).

    InhaLac® 300 thus provides an additional tool for formulators to tune and optimize the performance of their DPI products.

    About MEGGLE Wasserburg

    Bavarian-based MEGGLE is one of the world’s experts in co-processing and powder technology. From its roots as a dairy operation in the late 1880’s, MEGGLE has become one of the world’s leading manufacturers of pharmaceutical lactose, supplying the pharma market segment with a broad-based and unique lactose product portfolio.

    MEGGLE Excipients & Technology has harnessed outstanding product quality and intelligent innovation to become a global leader in the manufacture of lactose-based excipients, focusing on products for direct tableting and dry powder inhalation.

    A multidisciplinary team of committed and highly qualified people allows MEGGLE clients to benefit from pioneering experience and innovative drive in industrial milk and whey processing. The company constantly strives to develop high-tech, functional products for solid dosage forms and DPI applications, where they can deliver maximum performance.

    The company has introduced several pioneering products, notably Tablettose®, the world’s first agglomerated lactose for direct tableting, Cellactose® 80, a pioneering co-processed excipient based on cellulose-lactose for outstanding compression and flow properties and RetaLac®, the first direct compression co-processed excipient using a hypromellose-lactose base for sustained release formulations.

    To learn more, visit:

    About PBP World Meeting 2021

    The Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (PBP) World Meeting has become a well-established pharma industry event, attracting scientists from all over the world. The event is biennial, with previous meetings held in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow, and Granada (2018).

    The 12th PBP conference, World Meeting 2021, is a four-day event hosted online from May 11 that replaces the 2020 event originally to be held in Vienna and repurposed as a virtual conference due to the COVID-19 emergency. Across four parallel scientific tracks, the conference will cover the entire spectrum of pharmaceutical science topics, ranging from production engineering, latest insights on powder compaction and excipients, formulation, characterization, and product development challenges.

    The event is organized by ResearchPharm with further information at:


    Click on InhaLac brochure to download full product range information.


    Experts in Excipients - The whole world of Lactose

    MEGGLE showcasing latest DPI-focused InhaLac® 300 at PBP 2021

    Scanning electron microscope image of InhaLac® 300 showing its specific particle size distribution concentrated between 40 and 56 µm

    MEGGLE showcasing latest DPI-focused InhaLac® 300 at PBP 2021

    Contact MEGGLE Excipients

    Simply fill out the form below to contact MEGGLE Excipients now.

    Send MEGGLE Excipients a Message